Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Ann Hematol
1 Biochem Pharmacol
2 Blood
2 Br J Cancer
2 Eur J Haematol
3 Int J Hematol
1 J Clin Oncol
1 Leuk Lymphoma
3 Leuk Res
3 N Engl J Med
1 Oncogene
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Hematol

  1. LIU Y, Liu Y, Chen P, Chen G, et al
    GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy.
    Ann Hematol. 2024 Apr 27. doi: 10.1007/s00277-024-05777.
    PubMed         Abstract available

    Biochem Pharmacol

  2. CHIOU JT, Chang LS
    ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Biochem Pharmacol. 2024;224:116242.
    PubMed         Abstract available


  3. ROESSNER PM, Seufert I, Chapaprieta V, Jayabalan R, et al
    T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
    Blood. 2024 Apr 29:blood.2023021990. doi: 10.1182/blood.2023021990.
    PubMed         Abstract available

  4. KRAKOW EF, Brault M, Summers C, Cunningham TM, et al
    HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
    Blood. 2024 Apr 29:blood.2024024105. doi: 10.1182/blood.2024024105.
    PubMed         Abstract available

    Br J Cancer

  5. MEDRANO M, Contreras M, Caballero-Velazquez T, Martinez L, et al
    Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions.
    Br J Cancer. 2024;130:1529-1541.
    PubMed         Abstract available

  6. LITTLE MP, Mai JZ, Fang M, Chernyavskiy P, et al
    Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset.
    Br J Cancer. 2024 Feb 29. doi: 10.1038/s41416-024-02629.
    PubMed         Abstract available

    Eur J Haematol

  7. TAGHILOO S, Asgarian-Omran H
    Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review.
    Eur J Haematol. 2024 May 2. doi: 10.1111/ejh.14224.
    PubMed         Abstract available

  8. KUTSCH N, Giza A, Robrecht S, Stumpf J, et al
    Fludarabine, cyclophosphamide, and rituximab as first-line treatment in patients with chronic lymphocytic leukemia: A long-term analysis of the German CLL Study Group (GCLLSG) registry.
    Eur J Haematol. 2024 May 1. doi: 10.1111/ejh.14220.
    PubMed         Abstract available

    Int J Hematol

  9. KAITO Y, Imai Y
    Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.
    Int J Hematol. 2024 May 1. doi: 10.1007/s12185-024-03778.
    PubMed         Abstract available

  10. KATSUKI K, Tachibana T, Izumi A, Kim K, et al
    Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA-haploidentical transplantation with high donor-specific antibodies.
    Int J Hematol. 2024 Apr 27. doi: 10.1007/s12185-024-03775.
    PubMed         Abstract available

  11. TIEN FM, Hou HA
    CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment.
    Int J Hematol. 2024 Apr 26. doi: 10.1007/s12185-024-03773.
    PubMed         Abstract available

    J Clin Oncol

  12. SHORT NJ, Daver N, Dinardo CD, Kadia T, et al
    Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.
    J Clin Oncol. 2024;42:1499-1508.
    PubMed         Abstract available

    Leuk Lymphoma

  13. HUNTINGTON SF, Cheng WY, Sarpong EM, Leng S, et al
    Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study.
    Leuk Lymphoma. 2024 May 2:1-11. doi: 10.1080/10428194.2024.2331631.
    PubMed         Abstract available

    Leuk Res

  14. MOHEBBI A, Shahriyary F, Farrokhi V, Bandar B, et al
    A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia.
    Leuk Res. 2024;141:107505.
    PubMed         Abstract available

  15. SUN M, Li S, Liu Z, Ma S, et al
    Efficacy and safety of flumatinib in the treatment of newly diagnosed chronic myeloid leukemia in the chronic phase: A real-world single-center retrospective study, with a focus on premature drug discontinuation.
    Leuk Res. 2024;142:107507.
    PubMed         Abstract available

  16. DONG S, Premnath N, Sadeghi N, Kainthla R, et al
    Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.
    Leuk Res. 2024;141:107503.
    PubMed         Abstract available

    N Engl J Med

  17. MUNIR T, Hillmen P
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply.
    N Engl J Med. 2024;390:1634-1635.

  18. WANG WD, Gale RP, Liang Y
    Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
    N Engl J Med. 2024;390:1633-1634.

    Acute Promyelocytic Leukemia.
    N Engl J Med. 2024;390:e42.


  20. SAFFERTHAL C, Rohde K, Fulda S
    Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022.

    PLoS One

  21. EISSENBERG LG, Ritchey JK, Rettig MP, Patel DA, et al
    Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
    PLoS One. 2024;19:e0300174.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  22. KATERNDAHL CDS, Rogers ORS, Day RB, Xu Z, et al
    PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.
    Proc Natl Acad Sci U S A. 2024;121:e2317690121.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.